SRA's number for the day: 31
This article was originally published in SRA
Executive Summary
In 2012, 31% (34 out of 109) of the paediatric investigation plans (PIPs) that pharmaceutical companies submitted to the European Medicines Agency were sent late and missed the agency's submission deadline by six months or more1.